These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21805729)

  • 41. Unusual presentation of a small hepatocellular carcinoma: a case report.
    Lee WC; Chen MF; Jeng LB; Chen TC
    Hepatogastroenterology; 1997; 44(13):153-5. PubMed ID: 9058135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [AFP mRNA in the circulation].
    Matsumura M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():377-82. PubMed ID: 11761976
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical significance of p53 antibody].
    Shiota G; Kawasaki H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():356-61. PubMed ID: 11761972
    [No Abstract]   [Full Text] [Related]  

  • 44. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Suda T; Kawai H; Tamura Y; Igarashi M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():665-9. PubMed ID: 20960847
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnosis and treatment of multicentric occurrence of hepatocellular carcinoma].
    He ZP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):187-9. PubMed ID: 15059316
    [No Abstract]   [Full Text] [Related]  

  • 46. Hepatocellular carcinoma: pathology and liver biopsy.
    Kalinski T; Roessner A
    Dig Dis; 2009; 27(2):102-8. PubMed ID: 19546547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Amplification of peripheral blood insulin-like growth factor II-mRNA and its clinical significance in the diagnosis of hepatocellular carcinoma].
    Yao DF; Dong ZZ; Liu YH; Zhao L; Huang JF; Meng XY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):695-6. PubMed ID: 14636457
    [No Abstract]   [Full Text] [Related]  

  • 48. Diagnosis of small hepatocellular carcinoma.
    Sherman M
    Hepatology; 2005 Jul; 42(1):14-6. PubMed ID: 15962322
    [No Abstract]   [Full Text] [Related]  

  • 49. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 50. [Genomic analysis of hepatocellular carcinoma and its application to diagnosis].
    Murakami Y
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():458-61. PubMed ID: 20979296
    [No Abstract]   [Full Text] [Related]  

  • 51. Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Case report.
    Bedi DG; Kumar R; Morettin LB; Gourley K
    Eur J Radiol; 1988 May; 8(2):109-12. PubMed ID: 2838279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative analysis of factors in recurrence of hepatocellular carcinoma.
    Kanno T; Harihara S; Kinoshita H; Tamori A; Kim K; Kuroki T; Mizoguchi Y; Kobayashi K; Hirohashi K; Monna T
    Osaka City Med J; 1987 Dec; 33(2):121-35. PubMed ID: 2840621
    [No Abstract]   [Full Text] [Related]  

  • 53. Current status of treatment of hepatocellular carcinoma.
    Tang ZY
    Chin Med J (Engl); 1985 Apr; 98(4):257-64. PubMed ID: 2408825
    [No Abstract]   [Full Text] [Related]  

  • 54. [Combined hepatocellular carcinoma and cholangiocellular carcinoma].
    Maeda Y; Nishida M; Mori N; Tamesa T; Okada T; Tangoku A; Oka M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():401-5. PubMed ID: 11761981
    [No Abstract]   [Full Text] [Related]  

  • 55. Recent advances in tumor markers of human hepatocellular carcinoma.
    Yoon SK
    Intervirology; 2008; 51 Suppl 1():34-41. PubMed ID: 18544946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of liver biopsy in the diagnosis of carcinoma of the liver.
    Patwardhan JR; Kshirsagar VH; Gadgil RK
    Indian J Cancer; 1971 Dec; 8(4):258-62. PubMed ID: 4338761
    [No Abstract]   [Full Text] [Related]  

  • 57. Successful diagnosis and resection of icteric type hepatocellular carcinoma.
    Murakami Y; Yokoyama T; Kanehiro T; Uemura K; Sasaki M; Morifuji M; Sueda T
    Hepatogastroenterology; 2003; 50(53):1634-6. PubMed ID: 14571803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Why no consensus prognostic classification for hepatocellular carcinoma?].
    Barbare JC; Bellenguez A; Diouf M
    Rev Prat; 2013 Feb; 63(2):218-9. PubMed ID: 23513789
    [No Abstract]   [Full Text] [Related]  

  • 59. The new generation of hepatocellular markers.
    Mount S
    Cancer Cytopathol; 2012 Aug; 120(4):217-9. PubMed ID: 22760992
    [No Abstract]   [Full Text] [Related]  

  • 60. Magnetic resonance imaging characterization of hepatocellular carcinoma expressing progenitor cell markers.
    Ward SC; Rosen A
    Liver Int; 2012 Mar; 32(3):349-51. PubMed ID: 22309102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.